Sarah A. O'Dowd
General Counsel, Lam Research.
Companies
- Protagonist Therapeutics, IncBoard member Aug 18, 2020 to now1
- ICHOR HOLDINGS, LTD.Board member May 14, 2020 to May 17, 20242
- Lam ResearchGeneral counsel Oct 8, 2008 to Dec 23, 20193
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ICHOR HOLDINGS, LTD. ICHR28,325 shares4$1.2M at $43.87May 15, 2024
- Protagonist Therapeutics, Inc PTGX7,825 shares5$1.0M at $134.03Jan 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 2, 2026Granted 2,695 shares of Protagonist Therapeutics, Inc5
- Jan 2, 2025Granted 5,130 shares of Protagonist Therapeutics, Inc6
- May 15, 2024Granted 3,923 shares of ICHOR HOLDINGS, LTD.4
- May 18, 2023Granted 4,752 shares of ICHOR HOLDINGS, LTD.7
- May 24, 2022Granted 5,635 shares of ICHOR HOLDINGS, LTD.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARICHOR HOLDINGS, LTD., Board member
- 3SEC EDGARLam Research, General counsel
- 4
- 5
- 6SEC EDGARForm 4 filed Jan 6, 2025
- 7SEC EDGARForm 4 filed May 22, 2023
- 8SEC EDGARForm 4 filed May 26, 2022